Effects of vitamin therapy on plasma total homocysteine, endothelial injury markers, and fibrinolysis in stroke patients

Journal of Stroke and Cerebrovascular Diseases

Volumn 11, Issue 1, 2002, Pages 1-8

  Macko, Richard F ^a,b,c,d,e   Kittner, Steven J ^a,b,c,d,e   Ivey, Frederick M ^a,b,c,d,e   Epstein, Anne ^a,b,c,d,e   Sparks, Mary J ^a,b,c,d,e   Hebel, J Richard ^a,b,c,d,e   Johnson, Constance C ^a,b,c,d,e   Wityk, Robert J ^a,b,c,d,e   Ueland, Per M ^a,b,c,d,e   Refsum, Helga ^a,b,c,d,e  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SAINT THOMAS HOSPITAL   (United States)

^e UNIVERSITY OF BERGEN   (Norway)

Author keywords

Fibrinolysis; Homocysteine; Methionine load; Stroke; Thrombomodulin; Vitamin therapy

Indexed keywords

ACETYLSALICYLIC ACID; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; THROMBOMODULIN; TICLOPIDINE; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR; WARFARIN;

ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM INJURY; FEMALE; FIBRINOLYSIS; HEMODYNAMIC MONITORING; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; RECEPTOR BINDING; STROKE;

EID: 0036313934     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1053/jscd.2002.123968     Document Type: Article

References (41)

1. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men
2. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project
3. Homocysteine and cardiovascular disease
4. Vitamin status and intake as primary determinants of homocystinemia in an elderly population
5. Elevated plasma homocysteine concentration as a possible independent risk factor for stroke
6. Hyperhomocysteinaemia in stroke: Prevalence, cause and relationships to type of stroke and stroke risk factors
7. The natural history of homocystinuria due to cystathionine β-synthase deficiency
8. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine
9. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine
10. Homocysteine inhibits von Wille-brand factor processing and secretion by preventing transport from the endoplasmic reticulum
11. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor
12. The pathogenesis of homocystinemia: Interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine
13. Plasma homocysteine in the acute and convalescent phases after stroke
14. Altered coagulation in cerebral ischemia: Platelet, thrombin, and plasmin activity
15. Precipitants of brain infarction: The roles of preceding infection-inflammation and recent psychological stress
16. Impairments of the protein C system and fibrinolysis in infection-associated stroke
17. Validation of abbreviated oral methionine-loading test
18. Optimum conditions for the stabilization and measurement of tissue plasminogen activator activity in human plasma
19. Homocysteine and other thiols in plasma and urine: Automated determination and sample stability
20. A simplified method for determination of pyridoxal phosphate in biological samples
21. 12 levels: Its assay and significance
22. The protein C anticoagulant pathway
23. Plasma thrombomodulin in health and diseases
24. Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy
25. Serum thrombomodulin: A novel marker of disease activity in systemic lupus erythematosis
26. Levels of plasma thrombomodulin are increased in atheromatous arterial disease
27. High concentration of thrombomodulin in plasma is associated with hemorrhage: A prospective study in patients receiving long-term anticoagulant treatment
28. Increased levels of plasma thrombomodulin are associated with vascular and all-cause mortality in patients on long-term anticoagulant treatment
29. Hyperhomocystinemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease
30. Consequences of hyperhomocystinemia on vascular function in atherosclerotic monkeys
31. An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells
32. Von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death
33. Von Willebrand factor and risk of ischemic stroke
34. Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters
35. Plasma homocysteine and hemostasis: The ARIC study
36. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke
37. Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine
38. Prospective study of endogenous tissue plasminogen activator and risk of stroke
39. Elevated tissue plasminogen activator and stroke risk: The Stroke Prevention in Young Women Study
40. Fibrinolytic activity, clotting factors, and long-term incidence of ischemic heart disease in the Northwick Park Heart Study